{"count":220212,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1401","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1399","results":[{"created":"2021-02-25T21:05:18.610367+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6459","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: G6PC were set to ","entity_name":"G6PC","entity_type":"gene"},{"created":"2021-02-25T21:05:00.343400+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6458","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: G6PC was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"G6PC","entity_type":"gene"},{"created":"2021-02-25T21:04:40.726203+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6457","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: G6PC: Rating: GREEN; Mode of pathogenicity: None; Publications: 8733042; Phenotypes: Glycogen storage disease Ia, MIM# 232200; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"G6PC","entity_type":"gene"},{"created":"2021-02-25T21:01:32.972497+11:00","panel_name":"Glycogen Storage Diseases","panel_id":106,"panel_version":"0.46","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: G6PC as ready","entity_name":"G6PC","entity_type":"gene"},{"created":"2021-02-25T21:01:32.959512+11:00","panel_name":"Glycogen Storage Diseases","panel_id":106,"panel_version":"0.46","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: g6pc has been classified as Green List (High Evidence).","entity_name":"G6PC","entity_type":"gene"},{"created":"2021-02-25T21:01:28.908335+11:00","panel_name":"Glycogen Storage Diseases","panel_id":106,"panel_version":"0.46","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: G6PC were changed from  to Glycogen storage disease Ia, MIM# 232200","entity_name":"G6PC","entity_type":"gene"},{"created":"2021-02-25T21:00:53.534429+11:00","panel_name":"Glycogen Storage Diseases","panel_id":106,"panel_version":"0.45","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: G6PC were set to ","entity_name":"G6PC","entity_type":"gene"},{"created":"2021-02-25T21:00:38.072657+11:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.40","user_name":"Lavvina Thiyagarajan","item_type":"entity","text":"reviewed gene: ALPI: Rating: AMBER; Mode of pathogenicity: None; Publications: 32084423; Phenotypes: Inflammatory bowel disease; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"ALPI","entity_type":"gene"},{"created":"2021-02-25T21:00:30.953368+11:00","panel_name":"Glycogen Storage Diseases","panel_id":106,"panel_version":"0.44","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: G6PC was changed from BIALLELIC, autosomal or pseudoautosomal to BIALLELIC, autosomal or pseudoautosomal","entity_name":"G6PC","entity_type":"gene"},{"created":"2021-02-25T21:00:09.463863+11:00","panel_name":"Glycogen Storage Diseases","panel_id":106,"panel_version":"0.44","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: G6PC was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"G6PC","entity_type":"gene"},{"created":"2021-02-25T20:59:37.826794+11:00","panel_name":"Glycogen Storage Diseases","panel_id":106,"panel_version":"0.43","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: G6PC: Rating: GREEN; Mode of pathogenicity: None; Publications: 8733042; Phenotypes: Glycogen storage disease Ia, MIM# 232200; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"G6PC","entity_type":"gene"},{"created":"2021-02-25T20:58:03.166600+11:00","panel_name":"Glycogen Storage Diseases","panel_id":106,"panel_version":"0.43","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FBP1 as ready","entity_name":"FBP1","entity_type":"gene"},{"created":"2021-02-25T20:58:03.155906+11:00","panel_name":"Glycogen Storage Diseases","panel_id":106,"panel_version":"0.43","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fbp1 has been classified as Green List (High Evidence).","entity_name":"FBP1","entity_type":"gene"},{"created":"2021-02-25T20:57:59.890200+11:00","panel_name":"Glycogen Storage Diseases","panel_id":106,"panel_version":"0.43","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FBP1 were changed from  to Fructose-1,6-bisphosphatase deficiency, MIM# 229700","entity_name":"FBP1","entity_type":"gene"},{"created":"2021-02-25T20:57:38.547190+11:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.40","user_name":"Lavvina Thiyagarajan","item_type":"entity","text":"Deleted their review","entity_name":"ALPI","entity_type":"gene"},{"created":"2021-02-25T20:57:27.592030+11:00","panel_name":"Glycogen Storage Diseases","panel_id":106,"panel_version":"0.42","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: FBP1 were set to ","entity_name":"FBP1","entity_type":"gene"},{"created":"2021-02-25T20:56:46.932143+11:00","panel_name":"Glycogen Storage Diseases","panel_id":106,"panel_version":"0.41","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FBP1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"FBP1","entity_type":"gene"},{"created":"2021-02-25T20:56:16.033239+11:00","panel_name":"Glycogen Storage Diseases","panel_id":106,"panel_version":"0.40","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: FBP1: Rating: GREEN; Mode of pathogenicity: None; Publications: 9382095; Phenotypes: Fructose-1,6-bisphosphatase deficiency, MIM# 229700; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"FBP1","entity_type":"gene"},{"created":"2021-02-25T20:53:57.798215+11:00","panel_name":"Glycogen Storage Diseases","panel_id":106,"panel_version":"0.40","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: EPM2A as ready","entity_name":"EPM2A","entity_type":"gene"},{"created":"2021-02-25T20:53:57.789241+11:00","panel_name":"Glycogen Storage Diseases","panel_id":106,"panel_version":"0.40","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: epm2a has been classified as Green List (High Evidence).","entity_name":"EPM2A","entity_type":"gene"},{"created":"2021-02-25T20:53:54.775765+11:00","panel_name":"Glycogen Storage Diseases","panel_id":106,"panel_version":"0.40","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: EPM2A were changed from  to Epilepsy, progressive myoclonic 2A (Lafora), MIM# 254780","entity_name":"EPM2A","entity_type":"gene"},{"created":"2021-02-25T20:53:24.261998+11:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.40","user_name":"Lavvina Thiyagarajan","item_type":"entity","text":"changed review comment from: 2 unrelated individuals with inflammatory bowel disease. Some functional evidence. Additional recent publication in 2020 regarding ALPI but no new individuals described.; to: 2 unrelated individuals with inflammatory bowel disease. Some functional evidence. Additional recent publication (PMID: 32084423) in 2020 but no new individuals identified (patient described has previously been reported).","entity_name":"ALPI","entity_type":"gene"},{"created":"2021-02-25T20:53:20.967591+11:00","panel_name":"Glycogen Storage Diseases","panel_id":106,"panel_version":"0.39","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: EPM2A were set to ","entity_name":"EPM2A","entity_type":"gene"},{"created":"2021-02-25T20:52:46.236327+11:00","panel_name":"Glycogen Storage Diseases","panel_id":106,"panel_version":"0.38","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: EPM2A was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"EPM2A","entity_type":"gene"},{"created":"2021-02-25T20:52:14.113631+11:00","panel_name":"Glycogen Storage Diseases","panel_id":106,"panel_version":"0.37","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: EPM2A: Rating: GREEN; Mode of pathogenicity: None; Publications: 9771710; Phenotypes: Epilepsy, progressive myoclonic 2A (Lafora), MIM# 254780; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"EPM2A","entity_type":"gene"},{"created":"2021-02-25T20:50:57.042538+11:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.40","user_name":"Lavvina Thiyagarajan","item_type":"entity","text":"changed review comment from: 3 unrelated individuals with inflammatory bowel disease. Some functional evidence. Additional (3rd) individual described in recent (2020) publication with bi-allelic variants in ALPI.; to: 2 unrelated individuals with inflammatory bowel disease. Some functional evidence. Additional recent publication in 2020 regarding ALPI but no new individuals described.","entity_name":"ALPI","entity_type":"gene"},{"created":"2021-02-25T20:50:27.295318+11:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.40","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ALPI as ready","entity_name":"ALPI","entity_type":"gene"},{"created":"2021-02-25T20:50:27.291062+11:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.40","user_name":"Zornitza Stark","item_type":"entity","text":"Added comment: Comment when marking as ready: Family reported in PMID 32084423 is actually already previously reported.","entity_name":"ALPI","entity_type":"gene"},{"created":"2021-02-25T20:50:27.272412+11:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.40","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: alpi has been classified as Amber List (Moderate Evidence).","entity_name":"ALPI","entity_type":"gene"},{"created":"2021-02-25T20:49:50.834900+11:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.40","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ALPI as Amber List (moderate evidence)","entity_name":"ALPI","entity_type":"gene"},{"created":"2021-02-25T20:49:50.824591+11:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.40","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: alpi has been classified as Amber List (Moderate Evidence).","entity_name":"ALPI","entity_type":"gene"},{"created":"2021-02-25T20:49:02.669029+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6457","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ALPI as Amber List (moderate evidence)","entity_name":"ALPI","entity_type":"gene"},{"created":"2021-02-25T20:49:02.658620+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6457","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: alpi has been classified as Amber List (Moderate Evidence).","entity_name":"ALPI","entity_type":"gene"},{"created":"2021-02-25T20:48:45.713845+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6456","user_name":"Zornitza Stark","item_type":"entity","text":"changed review comment from: Third family reported 2020, PMID 32084423.; to: Family reported 2020, PMID 32084423 is actually already previously reported.","entity_name":"ALPI","entity_type":"gene"},{"created":"2021-02-25T20:48:22.634012+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6456","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: ALPI: Changed rating: AMBER","entity_name":"ALPI","entity_type":"gene"},{"created":"2021-02-25T17:10:40.588728+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6456","user_name":"Bryony Thompson","item_type":"entity","text":"Marked gene: NMNAT2 as ready","entity_name":"NMNAT2","entity_type":"gene"},{"created":"2021-02-25T17:10:40.581424+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6456","user_name":"Bryony Thompson","item_type":"entity","text":"Gene: nmnat2 has been classified as Amber List (Moderate Evidence).","entity_name":"NMNAT2","entity_type":"gene"},{"created":"2021-02-25T17:09:46.039960+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6456","user_name":"Bryony Thompson","item_type":"entity","text":"Marked gene: NMNAT2 as ready","entity_name":"NMNAT2","entity_type":"gene"},{"created":"2021-02-25T17:09:46.031675+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6456","user_name":"Bryony Thompson","item_type":"entity","text":"Gene: nmnat2 has been classified as Amber List (Moderate Evidence).","entity_name":"NMNAT2","entity_type":"gene"},{"created":"2021-02-25T17:07:40.833094+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6456","user_name":"Bryony Thompson","item_type":"entity","text":"Classified gene: NMNAT2 as Amber List (moderate evidence)","entity_name":"NMNAT2","entity_type":"gene"},{"created":"2021-02-25T17:07:40.822964+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6456","user_name":"Bryony Thompson","item_type":"entity","text":"Gene: nmnat2 has been classified as Amber List (Moderate Evidence).","entity_name":"NMNAT2","entity_type":"gene"},{"created":"2021-02-25T17:07:09.805153+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6455","user_name":"Bryony Thompson","item_type":"entity","text":"gene: NMNAT2 was added\ngene: NMNAT2 was added to Mendeliome. Sources: Literature\nMode of inheritance for gene: NMNAT2 was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: NMNAT2 were set to 31132363; 25271157; 20126265\nPhenotypes for gene: NMNAT2 were set to polyneuropathy; erythromelalgia\nReview for gene: NMNAT2 was set to AMBER\nAdded comment: A single family with siblings with a homozygous variant that confers a partial loss of function. Strong supporting functional evidence that the gene plays a key role in axonal survival. \nSources: Literature","entity_name":"NMNAT2","entity_type":"gene"},{"created":"2021-02-25T17:06:44.084144+11:00","panel_name":"Pain syndromes","panel_id":3126,"panel_version":"0.9","user_name":"Bryony Thompson","item_type":"entity","text":"Publications for gene: NMNAT2 were set to 31132363","entity_name":"NMNAT2","entity_type":"gene"},{"created":"2021-02-25T17:04:37.102480+11:00","panel_name":"Pain syndromes","panel_id":3126,"panel_version":"0.8","user_name":"Bryony Thompson","item_type":"entity","text":"Marked gene: NMNAT2 as ready","entity_name":"NMNAT2","entity_type":"gene"},{"created":"2021-02-25T17:04:37.091891+11:00","panel_name":"Pain syndromes","panel_id":3126,"panel_version":"0.8","user_name":"Bryony Thompson","item_type":"entity","text":"Gene: nmnat2 has been classified as Amber List (Moderate Evidence).","entity_name":"NMNAT2","entity_type":"gene"},{"created":"2021-02-25T17:04:33.048472+11:00","panel_name":"Pain syndromes","panel_id":3126,"panel_version":"0.8","user_name":"Bryony Thompson","item_type":"entity","text":"Classified gene: NMNAT2 as Amber List (moderate evidence)","entity_name":"NMNAT2","entity_type":"gene"},{"created":"2021-02-25T17:04:33.038296+11:00","panel_name":"Pain syndromes","panel_id":3126,"panel_version":"0.8","user_name":"Bryony Thompson","item_type":"entity","text":"Gene: nmnat2 has been classified as Amber List (Moderate Evidence).","entity_name":"NMNAT2","entity_type":"gene"},{"created":"2021-02-25T17:04:23.995726+11:00","panel_name":"Pain syndromes","panel_id":3126,"panel_version":"0.7","user_name":"Bryony Thompson","item_type":"entity","text":"reviewed gene: NMNAT2: Rating: AMBER; Mode of pathogenicity: None; Publications: 31132363, 25271157, 20126265; Phenotypes: Polyneuropathy with erythromelalgia; Mode of inheritance: None","entity_name":"NMNAT2","entity_type":"gene"},{"created":"2021-02-25T15:57:15.767963+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6454","user_name":"Bryony Thompson","item_type":"entity","text":"Phenotypes for gene: CCT5 were changed from  to Neuropathy, hereditary sensory, with spastic paraplegia MIM#256840","entity_name":"CCT5","entity_type":"gene"},{"created":"2021-02-25T15:56:59.180199+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6453","user_name":"Bryony Thompson","item_type":"entity","text":"Publications for gene: CCT5 were set to ","entity_name":"CCT5","entity_type":"gene"},{"created":"2021-02-25T15:56:33.438659+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6452","user_name":"Bryony Thompson","item_type":"entity","text":"Mode of inheritance for gene: CCT5 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CCT5","entity_type":"gene"},{"created":"2021-02-25T15:55:52.638463+11:00","panel_name":"Pain syndromes","panel_id":3126,"panel_version":"0.7","user_name":"Bryony Thompson","item_type":"entity","text":"Marked gene: CCT5 as ready","entity_name":"CCT5","entity_type":"gene"},{"created":"2021-02-25T15:55:52.630605+11:00","panel_name":"Pain syndromes","panel_id":3126,"panel_version":"0.7","user_name":"Bryony Thompson","item_type":"entity","text":"Gene: cct5 has been classified as Amber List (Moderate Evidence).","entity_name":"CCT5","entity_type":"gene"},{"created":"2021-02-25T15:55:41.300094+11:00","panel_name":"Pain syndromes","panel_id":3126,"panel_version":"0.7","user_name":"Bryony Thompson","item_type":"entity","text":"Classified gene: CCT5 as Amber List (moderate evidence)","entity_name":"CCT5","entity_type":"gene"},{"created":"2021-02-25T15:55:41.288318+11:00","panel_name":"Pain syndromes","panel_id":3126,"panel_version":"0.7","user_name":"Bryony Thompson","item_type":"entity","text":"Gene: cct5 has been classified as Amber List (Moderate Evidence).","entity_name":"CCT5","entity_type":"gene"},{"created":"2021-02-25T15:55:33.992765+11:00","panel_name":"Pain syndromes","panel_id":3126,"panel_version":"0.6","user_name":"Bryony Thompson","item_type":"entity","text":"reviewed gene: CCT5: Rating: AMBER; Mode of pathogenicity: None; Publications: 16399879, 25124038, 25345891, 12874111; Phenotypes: Neuropathy, hereditary sensory, with spastic paraplegia MIM#256840; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CCT5","entity_type":"gene"},{"created":"2021-02-25T15:45:15.981141+11:00","panel_name":"Pain syndromes","panel_id":3126,"panel_version":"0.6","user_name":"Bryony Thompson","item_type":"entity","text":"Marked gene: NAGLU as ready","entity_name":"NAGLU","entity_type":"gene"},{"created":"2021-02-25T15:45:15.972944+11:00","panel_name":"Pain syndromes","panel_id":3126,"panel_version":"0.6","user_name":"Bryony Thompson","item_type":"entity","text":"Gene: naglu has been classified as Amber List (Moderate Evidence).","entity_name":"NAGLU","entity_type":"gene"},{"created":"2021-02-25T15:44:55.644926+11:00","panel_name":"Pain syndromes","panel_id":3126,"panel_version":"0.6","user_name":"Bryony Thompson","item_type":"entity","text":"reviewed gene: NAGLU: Rating: AMBER; Mode of pathogenicity: None; Publications: 25818867; Phenotypes: ?Charcot-Marie-Tooth disease, axonal, type 2V MIM#616491; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"NAGLU","entity_type":"gene"},{"created":"2021-02-25T15:27:11.407616+11:00","panel_name":"Pain syndromes","panel_id":3126,"panel_version":"0.6","user_name":"Bryony Thompson","item_type":"entity","text":"Marked gene: MPV17 as ready","entity_name":"MPV17","entity_type":"gene"},{"created":"2021-02-25T15:27:11.397098+11:00","panel_name":"Pain syndromes","panel_id":3126,"panel_version":"0.6","user_name":"Bryony Thompson","item_type":"entity","text":"Gene: mpv17 has been classified as Red List (Low Evidence).","entity_name":"MPV17","entity_type":"gene"},{"created":"2021-02-25T15:27:03.284308+11:00","panel_name":"Pain syndromes","panel_id":3126,"panel_version":"0.6","user_name":"Bryony Thompson","item_type":"entity","text":"Classified gene: MPV17 as Red List (low evidence)","entity_name":"MPV17","entity_type":"gene"},{"created":"2021-02-25T15:27:03.269081+11:00","panel_name":"Pain syndromes","panel_id":3126,"panel_version":"0.6","user_name":"Bryony Thompson","item_type":"entity","text":"Gene: mpv17 has been classified as Red List (Low Evidence).","entity_name":"MPV17","entity_type":"gene"},{"created":"2021-02-25T15:26:53.373081+11:00","panel_name":"Pain syndromes","panel_id":3126,"panel_version":"0.5","user_name":"Bryony Thompson","item_type":"entity","text":"reviewed gene: MPV17: Rating: RED; Mode of pathogenicity: None; Publications: 22508010, 29282788; Phenotypes: Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) MIM#256810; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"MPV17","entity_type":"gene"},{"created":"2021-02-25T15:09:28.185658+11:00","panel_name":"Pain syndromes","panel_id":3126,"panel_version":"0.5","user_name":"Bryony Thompson","item_type":"entity","text":"Marked gene: TRPA1 as ready","entity_name":"TRPA1","entity_type":"gene"},{"created":"2021-02-25T15:09:28.168749+11:00","panel_name":"Pain syndromes","panel_id":3126,"panel_version":"0.5","user_name":"Bryony Thompson","item_type":"entity","text":"Gene: trpa1 has been classified as Amber List (Moderate Evidence).","entity_name":"TRPA1","entity_type":"gene"},{"created":"2021-02-25T15:09:21.819555+11:00","panel_name":"Pain syndromes","panel_id":3126,"panel_version":"0.5","user_name":"Bryony Thompson","item_type":"entity","text":"Classified gene: TRPA1 as Amber List (moderate evidence)","entity_name":"TRPA1","entity_type":"gene"},{"created":"2021-02-25T15:09:21.811392+11:00","panel_name":"Pain syndromes","panel_id":3126,"panel_version":"0.5","user_name":"Bryony Thompson","item_type":"entity","text":"Gene: trpa1 has been classified as Amber List (Moderate Evidence).","entity_name":"TRPA1","entity_type":"gene"},{"created":"2021-02-25T15:09:13.536946+11:00","panel_name":"Pain syndromes","panel_id":3126,"panel_version":"0.4","user_name":"Bryony Thompson","item_type":"entity","text":"reviewed gene: TRPA1: Rating: AMBER; Mode of pathogenicity: None; Publications: 28436534, 20547126; Phenotypes: ?Episodic pain syndrome, familial, 1 MIM#615040, Cramp-fasciculation syndrome; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"TRPA1","entity_type":"gene"},{"created":"2021-02-25T13:17:24.809836+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6451","user_name":"Bryony Thompson","item_type":"entity","text":"Marked gene: USF1 as ready","entity_name":"USF1","entity_type":"gene"},{"created":"2021-02-25T13:17:24.802059+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6451","user_name":"Bryony Thompson","item_type":"entity","text":"Gene: usf1 has been classified as Red List (Low Evidence).","entity_name":"USF1","entity_type":"gene"},{"created":"2021-02-25T13:16:20.377906+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6451","user_name":"Bryony Thompson","item_type":"entity","text":"Classified gene: USF1 as Red List (low evidence)","entity_name":"USF1","entity_type":"gene"},{"created":"2021-02-25T13:16:20.363208+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6451","user_name":"Bryony Thompson","item_type":"entity","text":"Gene: usf1 has been classified as Red List (Low Evidence).","entity_name":"USF1","entity_type":"gene"},{"created":"2021-02-25T13:16:02.000179+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6450","user_name":"Bryony Thompson","item_type":"entity","text":"reviewed gene: USF1: Rating: RED; Mode of pathogenicity: None; Publications: 14991056, 16076849, 31725952; Phenotypes: Hyperlipidemia, familial combined, susceptibility to MIM#602491; Mode of inheritance: Unknown","entity_name":"USF1","entity_type":"gene"},{"created":"2021-02-25T12:46:32.688256+11:00","panel_name":"Hereditary Neuropathy - complex","panel_id":3070,"panel_version":"0.107","user_name":"Bryony Thompson","item_type":"entity","text":"Classified gene: PDXK as Green List (high evidence)","entity_name":"PDXK","entity_type":"gene"},{"created":"2021-02-25T12:46:32.684438+11:00","panel_name":"Hereditary Neuropathy - complex","panel_id":3070,"panel_version":"0.107","user_name":"Bryony Thompson","item_type":"entity","text":"Added comment: Comment on list classification: Additional family identified","entity_name":"PDXK","entity_type":"gene"},{"created":"2021-02-25T12:46:32.666052+11:00","panel_name":"Hereditary Neuropathy - complex","panel_id":3070,"panel_version":"0.107","user_name":"Bryony Thompson","item_type":"entity","text":"Gene: pdxk has been classified as Green List (High Evidence).","entity_name":"PDXK","entity_type":"gene"},{"created":"2021-02-25T12:46:10.571827+11:00","panel_name":"Hereditary Neuropathy - complex","panel_id":3070,"panel_version":"0.106","user_name":"Bryony Thompson","item_type":"entity","text":"Publications for gene: PDXK were set to 31187503","entity_name":"PDXK","entity_type":"gene"},{"created":"2021-02-25T12:45:25.526876+11:00","panel_name":"Optic Atrophy","panel_id":149,"panel_version":"0.131","user_name":"Bryony Thompson","item_type":"entity","text":"Publications for gene: PDXK were set to 31187503","entity_name":"PDXK","entity_type":"gene"},{"created":"2021-02-25T12:44:43.757079+11:00","panel_name":"Optic Atrophy","panel_id":149,"panel_version":"0.130","user_name":"Bryony Thompson","item_type":"entity","text":"Classified gene: PDXK as Green List (high evidence)","entity_name":"PDXK","entity_type":"gene"},{"created":"2021-02-25T12:44:43.752047+11:00","panel_name":"Optic Atrophy","panel_id":149,"panel_version":"0.130","user_name":"Bryony Thompson","item_type":"entity","text":"Added comment: Comment on list classification: Additional family identified","entity_name":"PDXK","entity_type":"gene"},{"created":"2021-02-25T12:44:43.727569+11:00","panel_name":"Optic Atrophy","panel_id":149,"panel_version":"0.130","user_name":"Bryony Thompson","item_type":"entity","text":"Gene: pdxk has been classified as Green List (High Evidence).","entity_name":"PDXK","entity_type":"gene"},{"created":"2021-02-25T12:43:21.470250+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6450","user_name":"Bryony Thompson","item_type":"entity","text":"Publications for gene: PDXK were set to 31187503","entity_name":"PDXK","entity_type":"gene"},{"created":"2021-02-25T12:41:59.606806+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6449","user_name":"Bryony Thompson","item_type":"entity","text":"Classified gene: PDXK as Green List (high evidence)","entity_name":"PDXK","entity_type":"gene"},{"created":"2021-02-25T12:41:59.603352+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6449","user_name":"Bryony Thompson","item_type":"entity","text":"Added comment: Comment on list classification: Additional family published in 2020","entity_name":"PDXK","entity_type":"gene"},{"created":"2021-02-25T12:41:59.585549+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6449","user_name":"Bryony Thompson","item_type":"entity","text":"Gene: pdxk has been classified as Green List (High Evidence).","entity_name":"PDXK","entity_type":"gene"},{"created":"2021-02-25T12:33:32.735879+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6447","user_name":"Bryony Thompson","item_type":"entity","text":"Marked gene: LIPI as ready","entity_name":"LIPI","entity_type":"gene"},{"created":"2021-02-25T12:33:32.725142+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6447","user_name":"Bryony Thompson","item_type":"entity","text":"Gene: lipi has been classified as Red List (Low Evidence).","entity_name":"LIPI","entity_type":"gene"},{"created":"2021-02-25T12:33:12.630315+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6447","user_name":"Bryony Thompson","item_type":"entity","text":"Classified gene: LIPI as Red List (low evidence)","entity_name":"LIPI","entity_type":"gene"},{"created":"2021-02-25T12:33:12.618726+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6447","user_name":"Bryony Thompson","item_type":"entity","text":"Gene: lipi has been classified as Red List (Low Evidence).","entity_name":"LIPI","entity_type":"gene"},{"created":"2021-02-25T12:32:36.105341+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6446","user_name":"Bryony Thompson","item_type":"entity","text":"reviewed gene: LIPI: Rating: RED; Mode of pathogenicity: None; Publications: 12719377; Phenotypes: Hypertriglycidaemia, familial; Mode of inheritance: Unknown","entity_name":"LIPI","entity_type":"gene"},{"created":"2021-02-25T12:20:51.846625+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6446","user_name":"Bryony Thompson","item_type":"entity","text":"Marked gene: GALNT12 as ready","entity_name":"GALNT12","entity_type":"gene"},{"created":"2021-02-25T12:20:51.835816+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6446","user_name":"Bryony Thompson","item_type":"entity","text":"Gene: galnt12 has been classified as Red List (Low Evidence).","entity_name":"GALNT12","entity_type":"gene"},{"created":"2021-02-25T12:20:32.856691+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6446","user_name":"Bryony Thompson","item_type":"entity","text":"Classified gene: GALNT12 as Red List (low evidence)","entity_name":"GALNT12","entity_type":"gene"},{"created":"2021-02-25T12:20:32.847311+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6446","user_name":"Bryony Thompson","item_type":"entity","text":"Gene: galnt12 has been classified as Red List (Low Evidence).","entity_name":"GALNT12","entity_type":"gene"},{"created":"2021-02-25T12:20:14.761016+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6445","user_name":"Bryony Thompson","item_type":"entity","text":"reviewed gene: GALNT12: Rating: RED; Mode of pathogenicity: None; Publications: 19617566, 30523343, 29749045; Phenotypes: Colorectal cancer, susceptibility to, 1 MIM#608812; Mode of inheritance: Unknown","entity_name":"GALNT12","entity_type":"gene"},{"created":"2021-02-25T12:00:09.861355+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6445","user_name":"Bryony Thompson","item_type":"entity","text":"Tag somatic tag was added to gene: C1GALT1C1.","entity_name":"C1GALT1C1","entity_type":"gene"},{"created":"2021-02-25T11:50:56.704274+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6445","user_name":"Bryony Thompson","item_type":"entity","text":"Marked gene: ABCG2 as ready","entity_name":"ABCG2","entity_type":"gene"},{"created":"2021-02-25T11:50:56.695889+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6445","user_name":"Bryony Thompson","item_type":"entity","text":"Gene: abcg2 has been classified as Red List (Low Evidence).","entity_name":"ABCG2","entity_type":"gene"},{"created":"2021-02-25T11:50:44.341469+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.6445","user_name":"Bryony Thompson","item_type":"entity","text":"Classified gene: ABCG2 as Red List (low evidence)","entity_name":"ABCG2","entity_type":"gene"}]}